
Cefraz S 500mg/500mg Injection
Marketer
Cadwell Pharma Private Limited
Salt Composition
Cefoperazone (500mg) + Sulbactam (500mg)
Overview Cefraz S 500mg/500mg Injection
Cefraz S 500mg/500mg injectable solution is a dual-action antibiotic. It's indicated for treating diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administration must be overseen by a qualified medical practitioner. Adherence to the prescribed dosage schedule is crucial; complete the entire course, regardless of symptom improvement. Premature cessation may compromise its effectiveness. Commonly reported adverse effects include nausea, vomiting, diarrhea, and dyspepsia. Should these worsen, immediate medical consultation is necessary. Seek urgent medical attention for allergic responses (e.g., skin rashes, itching, edema, respiratory distress). Inform your physician of all current medications before commencing treatment. Expectant or nursing mothers require prior medical counsel. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, refrain from operating vehicles if experiencing somnolence or dizziness. Sufficient rest, nutritious food, and ample hydration promote optimal recovery. Your physician may order blood tests and other diagnostic procedures to monitor treatment efficacy.
Uses of Cefraz S 500mg/500mg Injection
Managing bacterial diseases
Major Benefits of Cefraz S 500mg/500mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Cefraz S 500mg/500mg Injection:
- Decreased white blood cell count (neutrophils)
- Decreased white blood cell count (lymphocytes)
- Decreased hemoglobin
- Decreased hematocrit level
- Low blood platelets
- Coagulation disorder
- Increased white blood cell count (eosinophils)
- Diarrhea
- Nausea
- Increased alanine aminotransferase
- Increased aspartate aminotransferase
- Increased alkaline phosphatase level in blood
- Vomiting
- Increased bilirubin in the blood
How to use Cefraz S 500mg/500mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Cefraz S 500mg/500mg Injection works:
Cefraz S 500mg/500mg Injection combines the antibiotic Cefoperazone with the beta-lactamase inhibitor Sulbactam. Cefoperazone's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Sulbactam counters bacterial resistance mechanisms, thereby boosting Cefoperazone's effectiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Cefraz S 500mg/500mg Injection and alcohol can trigger adverse reactions including facial flushing, tachycardia, nausea, polydipsia, chest discomfort, and hypotension (a disulfiram-like effect).
PregnancySAFE IF PRESCRIBED
Cefraz S 500mg/500mg injections are typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harmful consequences to the fetus; nevertheless, clinical data in pregnant women are scarce.
Breast feedingSAFE IF PRESCRIBED
Cefraz S 500mg/500mg injections pose minimal breastfeeding risk. Research in humans indicates negligible transfer to breast milk, with no associated harm to infants.
DrivingCONSULT YOUR DOCTOR
Cefraz S 500mg/500mg Injection's impact on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Cefraz S 500mg/500mg Injection use in individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cefraz S 500mg/500mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Cefraz S 500mg/500mg Injection :
Omit a Cefraz S 500mg/500mg Injection dose? Seek your physician's advice.
Facts to Know About Cefraz S 500mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Anti-infective agents |
